Back to top

TECHNOLOGY TRANSFER AGREEMENT

Technology License Assignment Agreement
TECHNOLOGY TRANSFER AGREEMENT You are currently viewing:
This Technology License Assignment Agreement involves

Bayer HealthCare LLC | MAXYGEN HOLDINGS LTD

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: TECHNOLOGY TRANSFER AGREEMENT
Governing Law: New York     Date: 8/5/2008
Industry: BIOTRX     Law Firm: Fulbright Jaworski     Sector: HEALTH

Search Technology License Assignment Agreement by:

Document Title:

Entire Document: (optional)

50 of the Top 250 law firms use our Products every day
exv2w1

Exhibit 2.1

Certain information in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

Technology Transfer Agreement

By and Among

Maxygen, Inc.

Maxygen Holdings Ltd.

Maxygen ApS

and

Bayer HealthCare LLC

Dated July 1, 2008

 

 

TABLE OF CONTENTS

 

 

 

 

 

ARTICLE 1 DEFINITIONS AND CONSTRUCTION

 

 

1

 

 

 

 

 

 

1.1 AAA

 

 

1

 

 

 

 

 

 

1.2 Acquired Assets

 

 

1

 

 

 

 

 

 

1.3 Acquired Books and Records

 

 

1

 

 

 

 

 

 

1.4 Acquired Intellectual Property

 

 

1

 

 

 

 

 

 

1.5 Affiliate

 

 

2

 

 

 

 

 

 

1.6 Agreement

 

 

2

 

 

 

 

 

 

1.7 Alternative Compound

 

 

2

 

 

 

 

 

 

1.8 Alternative Compound Fee

 

 

2

 

 

 

 

 

 

1.9 Applicable Law

 

 

2

 

 

 

 

 

 

1.10 Assigned Third Party Agreements

 

 

2

 

 

 

 

 

 

1.11 Assignment and Assumption Agreements

 

 

2

 

 

 

 

 

 

1.12 Assumed Liabilities

 

 

2

 

 

 

 

 

 

1.13 Backup Compound Fee

 

 

2

 

 

 

 

 

 

1.14 Backup Compounds

 

 

2

 

 

 

 

 

 

1.15 Bayer Facility

 

 

2

 

 

 

 

 

 

1.16 Bayer Confidential Information

 

 

3

 

 

 

 

 

 

1.17 Bayer Indemnified Parties

 

 

3

 

 

 

 

 

 

1.18 Bayer’s Licensed-Back Confidential Information

 

 

3

 

 

 

 

 

 

1.19 Bayer’s Licensed Confidential Information

 

 

3

 

 

 

 

 

 

1.20 Bayer Material Adverse Effect

 

 

3

 

 

 

 

 

 

1.21 Bayer’s Other Confidential Information

 

 

3

 

 

 

 

 

 

1.22 Bill of Sale

 

 

3

 

 

 

 

 

 

1.23 Books and Records

 

 

3

 

 

 

 

 

 

1.24 Business Day

 

 

3

 

 

 

 

 

 

1.25 Challenge

 

 

3

 

 

 

 

 

 

1.26 Clinical Trials

 

 

3

 

 

 

 

 

 

1.27 Closing

 

 

3

 

 

 

 

 

 

1.28 Closing Date

 

 

4

 

 

 

 

 

 

1.29 Commencement

 

 

4

 

 

 

 

 

 

1.30 Compound

 

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

1.31 Compound Fee

 

 

4

 

 

 

 

 

 

1.32 Confidential Information

 

 

4

 

 

 

 

 

 

1.33 CTA

 

 

5

 

 

 

 

 

 

1.34 Disclosure Schedules

 

 

5

 

 

 

 

 

 

1.35 Dispute

 

 

5

 

 

 

 

 

 

1.36 Dollars or $

 

 

5

 

 

 

 

 

 

1.37 DMC

 

 

5

 

 

 

 

 

 

1.38 Emails

 

 

5

 

 

 

 

 

 

1.39 EMEA

 

 

5

 

 

 

 

 

 

1.40 EPO

 

 

5

 

 

 

 

 

 

1.41 Europe

 

 

5

 

 

 

 

 

 

1.42 European Union

 

 

5

 

 

 

 

 

 

1.43 Excluded Activities

 

 

5

 

 

 

 

 

 

1.44 Excluded Books and Records

 

 

6

 

 

 

 

 

 

1.45 Exclusivity Field

 

 

6

 

 

 

 

 

 

1.46 Exclusivity Period

 

 

6

 

 

 

 

 

 

1.47 Execution Date

 

 

6

 

 

 

 

 

 

1.48 Factor VII Compound

 

 

6

 

 

 

 

 

 

1.49 FDA

 

 

6

 

 

 

 

 

 

1.50 Field

 

 

6

 

 

 

 

 

 

1.51 FTE

 

 

6

 

 

 

 

 

 

1.52 GLP

 

 

6

 

 

 

 

 

 

1.53 GMP or Good Manufacturing Practices

 

 

6

 

 

 

 

 

 

1.54 Governmental Approval

 

 

6

 

 

 

 

 

 

1.55 Governmental Authority

 

 

6

 

 

 

 

 

 

1.56 IND

 

 

7

 

 

 

 

 

 

1.57 Indemnified Party

 

 

7

 

 

 

 

 

 

1.58 Indemnifying Party

 

 

7

 

 

 

 

 

 

1.59 Initial Enrollment Period

 

 

7

 

 

 

 

 

 

1.60 Intellectual Property

 

 

7

 

 

 

 

 

 

1.61 Intellectual Property Cross License

 

 

7

 

 

 

 

 

 

1.62 Inventory

 

 

7

 

 

 

 

 

 

1.63 Know-How

 

 

7

 

 

 

 

 

 

-ii-

 

 

 

 

 

 

1.64 Knowledge

 

 

8

 

 

 

 

 

 

1.65 Laboratory Notebooks

 

 

8